Hyperbaric oxygen improves engraftment of ex-vivo expanded and gene transduced human CD34+ cells in a murine model of umbilical cord blood transplantation

Blood Cells, Molecules, and Diseases

Volumn 52, Issue 1, 2014, Pages 59-67

  Aljitawi, Omar S ^a   Xiao, Yinghua ^a   Eskew, Jeff D ^b   Parelkar, Nikhil K ^b   Swink, Megan ^b   Radel, Jeff ^a   Lin, Tara L ^a   Kimler, Bruce F ^c   Mahnken, Jonathan D ^c   McGuirk, Joseph P ^a   Broxmeyer, Hal E ^d   Vielhauer, George ^b,c  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS CANCER CENTER   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD34+; Engraftment; Hyperbaric oxygen; Umbilical cord blood

Indexed keywords

LENTIVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BLOOD; BONE MARROW; CD34 SELECTION; CELL DENSITY; CELLULAR DISTRIBUTION; CELLULAR PARAMETERS; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ENGRAFTMENT; FEMALE; HUMAN; HUMAN CELL; HYPERBARIC OXYGEN; IRRADIATION; MOUSE; NONHUMAN; PHOTON FLUX; PRIORITY JOURNAL; SPLEEN;

LENTIVIRUS; MURINAE; MUS;

CD34(+); ENGRAFTMENT; HYPERBARIC OXYGEN; UMBILICAL CORD BLOOD;

ANIMALS; ANTIGENS, CD34; B-LYMPHOCYTE SUBSETS; BONE MARROW CELLS; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GENE EXPRESSION; GENES, REPORTER; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; HYPERBARIC OXYGENATION; INJECTIONS, INTRAVENOUS; LUCIFERASES; MICE; MICE, INBRED STRAINS; SPLEEN; TRANSPLANTATION, HETEROLOGOUS; WHOLE-BODY IRRADIATION;

EID: 84888323716     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2013.07.013     Document Type: Article

References (30)

1. Broxmeyer H.E., Farag S.S., Rocha V. Cord Blood Hematopoietic Cell Transplantation. Thomas' Hematopoietic Cell Transplantation 2013, Wiley-Blackwell, Oxford, England. 5th edition. F.R. Appelbaum, S.J. Forman, R.S. Negrin, J.H. Antin (Eds.).
2. Migliaccio A.R., Adamson J.W., Stevens C.E., et al. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000, 96:2717-2722.
3. Ballen K.K., Gluckman E., Broxmeyer H.E. Umbilical cord blood transplantation: the first 25years and beyond. Blood 2013, 122(4):491-498.
4. Szabolcs P., Niedzwiecki D. Immune reconstitution after unrelated cord blood transplantation. Cytotherapy 2007, 9:111-122.
5. Brown J.A., Boussiotis V.A. Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clin. Immunol. 2008, 127:286-297.
6. Komanduri K.V., St John L.S., de Lima M., et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood 2007, 110:4543-4551.
7. Szabolcs P., Cairo M.S. Unrelated umbilical cord blood transplantation and immune reconstitution. Semin. Hematol. 2010, 47:22-36.
8. Vandenbosch K., Ovetchkine P., Champagne M.A., et al. Varicella-zoster virus disease is more frequent after cord blood than after bone marrow transplantation. Biol. Blood Marrow Transplant. 2008, 14:867-871.
9. Nilsson S.K., Simmons P.J. Transplantable stem cells: home to specific niches. Curr. Opin. Hematol. 2004, 11:102-106.
10. Lapidot T., Dar A., Kollet O. How do stem cells find their way home?. Blood 2005, 106:1901-1910.
11. Ceradini D.J., Kulkarni A.R., Callaghan M.J., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 2004, 10:858-864.
12. Lapidot T., Kollet O. The brain-bone-blood triad: traffic lights for stem-cell homing and mobilization. Hematology Am. Soc. Hematol. Educ. Program 2010, 2010:1-6.
13. Christopherson K.W., Hangoc G., Mantel C.R., Broxmeyer H.E. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 2004, 305:1000-1003.
14. Campbell T.B., Hangoc G., Liu Y., Pollok K., Broxmeyer H.E. Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice. Stem Cells Dev. 2007, 16:347-354.
15. Broxmeyer H.E., Hoggatt J., O'Leary H.A., et al. Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis. Nat. Med. 2012, 18:1786-1796.
16. Farag S.S., Srivastava S., Messina-Graham S., et al. In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies. Stem Cells Dev. 2013, 22:1007-1015.
17. Frassoni F., Gualandi F., Podesta M., et al. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. Lancet Oncol. 2008, 9:831-839.
18. Brunstein C.G., Barker J.N., Weisdorf D.J., et al. Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. Bone Marrow Transplant. 2009, 43:935-940.
19. Hidalgo A., Frenette P.S. Enforced fucosylation of neonatal CD34+ cells generates selectin ligands that enhance the initial interactions with microvessels but not homing to bone marrow. Blood 2005, 105:567-575.
20. Robinson S.N., Simmons P.J., Thomas M.W., et al. Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rgamma(null) mice. Exp. Hematol. 2012, 40:445-456.
21. Grim P.S., Gottlieb L.J., Boddie A., Batson E. Hyperbaric oxygen therapy. JAMA 1990, 263:2216-2220.
22. Ito M., Hiramatsu H., Kobayashi K., et al. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002, 100:3175-3182.
23. Wrzesinski S., Seguin R., Liu Y., et al. HTLV type 1 Tax transduction in microglial cells and astrocytes by lentiviral vectors. AIDS Res. Hum. Retroviruses 2000, 16:1771-1776.
24. Steiner D., Gelovani J., Savoldo B., et al. Noninvasive bioluminescent imaging demonstrates long-term multilineage engraftment of ex vivo-expanded CD34-selected umbilical cord blood cells. Stem Cells 2009, 27:1932-1940.
25. Wang X., Rosol M., Ge S., et al. Dynamic tracking of human hematopoietic stem cell engraftment using in vivo bioluminescence imaging. Blood 2003, 102:3478-3482.
26. Ahmed F., Ings S.J., Pizzey A.R., et al. Impaired bone marrow homing of cytokine-activated CD34+ cells in the NOD/SCID model. Blood 2004, 103:2079-2087.
27. Larochelle A., Gillette J.M., Desmond R., et al. Bone marrow homing and engraftment of human hematopoietic stem and progenitor cells is mediated by a polarized membrane domain. Blood 2012, 119:1848-1855.
28. Peters S.O., Kittler E.L., Ramshaw H.S., Quesenberry P.J. Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts. Exp. Hematol. 1995, 23:461-469.
29. Noort W.A., Wilpshaar J., Hertogh C.D., et al. Similar myeloid recovery despite superior overall engraftment in NOD/SCID mice after transplantation of human CD34(+) cells from umbilical cord blood as compared to adult sources. Bone Marrow Transplant. 2001, 28:163-171.
30. Tibbles P.M., Edelsberg J.S. Hyperbaric-oxygen therapy. N. Engl. J. Med. 1996, 334:1642-1648.